StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience total assets

Total assets on the balance sheet at the end of each period.

Zivo Bioscience's total assets was $559.45K at Sep 30, 2025. For fiscal 2024 it was $1.64M, up 195.7% from the year before. Over ten years it grew 32.1% a year on average. The highest annual figure on record is $8.99M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2024Dec 31, 2024$1.64M+195.7%
FY2023Dec 31, 2023$555.72K-73.8%
FY2022Dec 31, 2022$2.12M-76.4%
FY2021Dec 31, 2021$8.99M+3983.1%
FY2020Dec 31, 2020$220.18K-40.4%
FY2019Dec 31, 2019$369.39K-10.2%
FY2018Dec 31, 2018$411.51K+23.8%
FY2017Dec 31, 2017$332.28K-54.9%
FY2016Dec 31, 2016$737.29K+914.4%
FY2015Dec 31, 2015$72.68K-28.6%
FY2014Dec 31, 2014$101.86K-95.3%
FY2013Dec 31, 2013$2.17M+829.2%
FY2012Dec 31, 2012$234.00K-49.5%
FY2011Dec 31, 2011$463.49K+36.4%
FY2010Dec 31, 2010$339.92K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$559.45K+12.9%
Q2 FY2025Jun 30, 2025$703.33K+22.2%
Q1 FY2025Mar 31, 2025$1.33M+63.1%
Q4 FY2024Dec 31, 2024$1.64M+195.7%
Q3 FY2024Sep 30, 2024$495.59K-76.4%
Q2 FY2024Jun 30, 2024$575.59K-19.0%
Q1 FY2024Mar 31, 2024$816.40K-27.6%
Q4 FY2023Dec 31, 2023$555.72K-73.8%
Q3 FY2023Sep 30, 2023$2.10M-47.1%
Q2 FY2023Jun 30, 2023$710.33K-87.9%
Q1 FY2023Mar 31, 2023$1.13M-85.3%
Q4 FY2022Dec 31, 2022$2.12M-76.4%
Q3 FY2022Sep 30, 2022$3.97M-63.8%
Q2 FY2022Jun 30, 2022$5.86M-47.2%
Q1 FY2022Mar 31, 2022$7.69M+1084.8%
Q4 FY2021Dec 31, 2021$8.99M+3983.1%
Q3 FY2021Sep 30, 2021$10.97M+8311.2%
Q2 FY2021Jun 30, 2021$11.10M+4885.8%
Q1 FY2021Mar 31, 2021$648.88K+262.7%
Q4 FY2020Dec 31, 2020$220.18K-40.4%
Q3 FY2020Sep 30, 2020$130.44K+86.6%
Q2 FY2020Jun 30, 2020$222.70K+98.4%
Q1 FY2020Mar 31, 2020$178.92K+72.4%
Q4 FY2019Dec 31, 2019$369.39K-10.2%
Q3 FY2019Sep 30, 2019$69.90K-74.9%
Q2 FY2019Jun 30, 2019$112.23K-84.8%
Q1 FY2019Mar 31, 2019$103.76K-96.3%
Q4 FY2018Dec 31, 2018$411.51K+23.8%
Q3 FY2018Sep 30, 2018$278.53K-80.5%
Q2 FY2018Jun 30, 2018$739.67K+259.9%
Q1 FY2018Mar 31, 2018$2.79M+125.0%
Q4 FY2017Dec 31, 2017$332.28K-54.9%
Q3 FY2017Sep 30, 2017$1.43M+90.6%
Q2 FY2017Jun 30, 2017$205.54K+126.3%
Q1 FY2017Mar 31, 2017$1.24M+254.3%
Q4 FY2016Dec 31, 2016$737.29K+914.4%
Q3 FY2016Sep 30, 2016$749.91K–
Q2 FY2016Jun 30, 2016$90.85K–
Q1 FY2016Mar 31, 2016$349.60K–
Q4 FY2015Dec 31, 2015$72.68K–

More Zivo Bioscience figures

See a number that looks wrong?